Cambridge Investment Research Advisors’s Aceragen, Inc. Common Stock ACGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-636
| Closed | -$4K | – | 3287 |
|
|
2022
Q4 | $4K | Buy |
+636
| New | +$4K | ﹤0.01% | 3091 |
|
|
2018
Q3 | – | Sell |
-132
| Closed | -$24K | – | 2320 |
|
|
2018
Q2 | $24K | Hold |
132
| – | – | ﹤0.01% | 2186 |
|
|
2018
Q1 | $33K | Hold |
132
| – | – | ﹤0.01% | 2116 |
|
|
2017
Q4 | $38K | Hold |
132
| – | – | ﹤0.01% | 2076 |
|
|
2017
Q3 | $40K | Hold |
132
| – | – | ﹤0.01% | 1963 |
|
|
2017
Q2 | $31K | Hold |
132
| – | – | ﹤0.01% | 1901 |
|
|
2017
Q1 | $44K | Hold |
132
| – | – | ﹤0.01% | 1734 |
|
|
2016
Q4 | $27K | Hold |
132
| – | – | ﹤0.01% | 1641 |
|
|
2016
Q3 | $46K | Hold |
132
| – | – | ﹤0.01% | 1703 |
|
|
2016
Q2 | $28K | Sell |
132
-30
| -19% | -$6.36K | ﹤0.01% | 1530 |
|
|
2016
Q1 | $44K | Buy |
162
+15
| +10% | +$4.07K | ﹤0.01% | 1560 |
|
|
2015
Q4 | $62K | Hold |
147
| – | – | ﹤0.01% | 1522 |
|
|
2015
Q3 | $67K | Hold |
147
| – | – | ﹤0.01% | 1376 |
|
|
2015
Q2 | $74K | Hold |
147
| – | – | ﹤0.01% | 1384 |
|
|
2015
Q1 | $74K | Hold |
147
| – | – | ﹤0.01% | 1356 |
|
|
2014
Q4 | $88K | Sell |
147
-37
| -20% | -$22.2K | ﹤0.01% | 1300 |
|
|
2014
Q3 | $57K | Hold |
184
| – | – | ﹤0.01% | 1422 |
|
|
2014
Q2 | $73K | Buy |
184
+22
| +14% | +$8.73K | ﹤0.01% | 1299 |
|
|
2014
Q1 | $90K | Buy |
162
+30
| +23% | +$16.7K | ﹤0.01% | 1245 |
|
|
2013
Q4 | $83K | Buy |
+132
| New | +$83K | ﹤0.01% | 1188 |
|